Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Myeloid Neoplasms with Isolated Isochromosome 17q: a yet to be Defined Entity.
Lamprianidou E, Kordella C, Papoutselis M, Bezyrgiannidou Z, Nakou E, Papamichos S, Spanoudakis E, Giannopoulos A, Zoi K, Kotsianidis I. Lamprianidou E, et al. Among authors: papoutselis m. Mediterr J Hematol Infect Dis. 2017 Nov 1;9(1):e2017066. doi: 10.4084/MJHID.2017.066. eCollection 2017. Mediterr J Hematol Infect Dis. 2017. PMID: 29181143 Free PMC article.
Eluate testing with monospecific antisera unmasks multiple immunoglobulin classes and identifies frequent IgA involvement in severe autoimmune hemolytic anemia.
Bezirgiannidou Z, Kontekaki E, Christoforidou A, Zisaki S, Chouchos K, Papamichos S, Vrachiolias G, Papoutselis M, Spanoudakis E, Martinis G, Kotsianidis I, Mantadakis E. Bezirgiannidou Z, et al. Among authors: papoutselis m. Transfus Apher Sci. 2018 Jun;57(3):384-387. doi: 10.1016/j.transci.2018.04.020. Epub 2018 Apr 22. Transfus Apher Sci. 2018. PMID: 29716828 No abstract available.
The JAK2V617F Point Mutation Increases the Osteoclast Forming Ability of Monocytes in Patients with Chronic Myeloproliferative Neoplasms and Makes their Osteoclasts more Susceptible to JAK2 Inhibition.
Spanoudakis E, Papoutselis M, Bazdiara I, Lamprianidi E, Kordella X, Tilkeridis C, Tsatalas C, Kotsianidis I. Spanoudakis E, et al. Among authors: papoutselis m. Mediterr J Hematol Infect Dis. 2018 Nov 1;10(1):e2018058. doi: 10.4084/MJHID.2018.058. eCollection 2018. Mediterr J Hematol Infect Dis. 2018. PMID: 30416690 Free PMC article.
Immunoporosis: A New Role for Invariant Natural Killer T (NKT) Cells Through Overexpression of Nuclear Factor-κB Ligand (RANKL).
Tilkeridis K, Kiziridis G, Ververidis A, Papoutselis M, Kotsianidis I, Kitsikidou G, Tousiaki NE, Drosos G, Kapetanou A, Rechova KV, Kazakos K, Spanoudakis E. Tilkeridis K, et al. Among authors: papoutselis m. Med Sci Monit. 2019 Mar 23;25:2151-2158. doi: 10.12659/MSM.912119. Med Sci Monit. 2019. PMID: 30903656 Free PMC article.
Multifaceted modes of action of azacytidine: a riddle wrapped up in an enigma.
Lamprianidou E, Zoulia E, Bernard E, Kordella C, Papoutselis M, Bezirgiannidou Z, Vrachiolias G, Papaemmanuil E, Kotsianidis I. Lamprianidou E, et al. Among authors: papoutselis m. Leuk Lymphoma. 2019 Dec;60(13):3277-3281. doi: 10.1080/10428194.2019.1627542. Epub 2019 Jun 12. Leuk Lymphoma. 2019. PMID: 31185765 No abstract available.
Azacytidine Failure Revisited: an Appraisal Based on Real-Life Data from the MDS Registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS).
Kotsianidis I, Papageorgiou SG, Pappa V, Galanopoulos AG, Viniou NA, Vassilakopoulos TP, Papoutselis M, Vrachiolias G, Papadopoulos V, Diamantopoulos PT, Tsokanas D, Kourakli A, Symeonidis A. Kotsianidis I, et al. Among authors: papoutselis m. Mediterr J Hematol Infect Dis. 2019 Jul 1;11(1):e2019045. doi: 10.4084/MJHID.2019.045. eCollection 2019. Mediterr J Hematol Infect Dis. 2019. PMID: 31308921 Free PMC article. No abstract available.
29 results